CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
weight management program +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00169702
NCT00169702N/ACompleted
CompareCT.gov

The Effect of a Weight Management Program to Prevent Weight Gain and Metabolic Abnormalities During Treatment With the Atypical Neuroleptic Olanzapine: A Randomised Study

Heinrich-Heine University, Duesseldorf·interventional·Posted Sep 15, 2005·Updated Jan 30, 2008

In Brief

A clinical study evaluating weight management program for Schizophrenia. Completed, enrolled 100 participants across 1 site.

Detailed Summary

The study is a prospective, randomized, open-label study.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSchizophrenia
CountriesGermany
CollaboratorsEli Lilly and Company, Else Kröner Fresenius Foundation, Technical University of Munich

Timeline

N/ACompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 15, 2005
Enrollment StartJun 1, 2003
Study CompletionJul 1, 2007
TodayJul 2, 2026
Posted 20.8 years ago

Interventions

weight management programbehavioral

12 sessions, psychoeducation

weight management programbehavioral

2 weekly, 12 sessions, psychoeducational weight management